Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 52

1.

Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes.

Caocci G, Voso MT, Angelucci E, Stauder R, Cottone F, Abel G, Nguyen K, Platzbecker U, Beyne-Rauzy O, Gaidano G, Invernizzi R, Molica S, Criscuolo M, Breccia M, Lübbert M, Sanpaolo G, Buccisano F, Ricco A, Palumbo GA, Niscola P, Zhang H, Fenu S, La Nasa G, Mandelli F, Efficace F.

Leuk Res. 2015 Aug;39(8):859-65. doi: 10.1016/j.leukres.2015.05.012. Epub 2015 Jun 12.

PMID:
26120100
2.

T cell tyrosine phosphorylation response to transient redox stress.

Secchi C, Carta M, Crescio C, Spano A, Arras M, Caocci G, Galimi F, La Nasa G, Pippia P, Turrini F, Pantaleo A.

Cell Signal. 2015 Apr;27(4):777-88. doi: 10.1016/j.cellsig.2014.12.014. Epub 2015 Jan 6.

PMID:
25572700
3.

Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes.

Efficace F, Gaidano G, Breccia M, Criscuolo M, Cottone F, Caocci G, Bowen D, Lübbert M, Angelucci E, Stauder R, Selleslag D, Platzbecker U, Sanpaolo G, Jonasova A, Buccisano F, Specchia G, Palumbo GA, Niscola P, Wan C, Zhang H, Fenu S, Klimek V, Beyne-Rauzy O, Nguyen K, Mandelli F.

Br J Haematol. 2015 Feb;168(3):361-70. doi: 10.1111/bjh.13138. Epub 2014 Oct 1.

PMID:
25272332
4.

Leucocyte classification for leukaemia detection using image processing techniques.

Putzu L, Caocci G, Di Ruberto C.

Artif Intell Med. 2014 Nov;62(3):179-91. doi: 10.1016/j.artmed.2014.09.002. Epub 2014 Sep 16.

PMID:
25241903
5.

Safe discontinuation of nilotinib in a patient with chronic myeloid leukemia: a case report.

Caocci G, Greco M, La Nasa G.

J Med Case Rep. 2014 Sep 6;8:295. doi: 10.1186/1752-1947-8-295.

6.

Reassessing the approach to informed consent: the case of unrelated hematopoietic stem cell transplantation in adult thalassemia patients.

Pisu S, Caocci G, d'Aloja E, Efficace F, Vacca A, Piras E, Orofino MG, Addari C, Pintor M, Demontis R, Demuru F, Pittau MR, Collins GS, La Nasa G.

Philos Ethics Humanit Med. 2014 Aug 12;9:13. doi: 10.1186/1747-5341-9-13.

7.

Immunological deregulation in classic hodgkin lymphoma.

Romano A, Vetro C, Caocci G, Greco M, Parrinello NL, Di Raimondo F, La Nasa G.

Mediterr J Hematol Infect Dis. 2014 Jun 1;6(1):e2014039. doi: 10.4084/MJHID.2014.039. eCollection 2014. Review.

8.

Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial).

Angelucci E, Santini V, Di Tucci AA, Quaresmini G, Finelli C, Volpe A, Quarta G, Rivellini F, Sanpaolo G, Cilloni D, Salvi F, Caocci G, Molteni A, Vallisa D, Voso MT, Fenu S, Borin L, Latte G, Alimena G, Storti S, Piciocchi A, Fazi P, Vignetti M, Tura S.

Eur J Haematol. 2014 Jun;92(6):527-36. doi: 10.1111/ejh.12300. Epub 2014 Apr 10.

PMID:
24580147
9.

Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromes.

Efficace F, Gaidano G, Sprangers M, Cottone F, Breccia M, Voso MT, Caocci G, Stauder R, Di Tucci AA, Sanpaolo G, Selleslag D, Angelucci E, Platzbecker U, Mandelli F.

Ann Oncol. 2014 Feb;25(2):447-54. doi: 10.1093/annonc/mdt557.

10.
11.

International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients: the EORTC QLQ-CML24.

Efficace F, Baccarani M, Breccia M, Saussele S, Abel G, Caocci G, Guilhot F, Cocks K, Naeem A, Sprangers M, Oerlemans S, Chie W, Castagnetti F, Bombaci F, Sharf G, Cardoni A, Noens L, Pallua S, Salvucci M, Nicolatou-Galitis O, Rosti G, Mandelli F.

Qual Life Res. 2014 Apr;23(3):825-36. doi: 10.1007/s11136-013-0523-5. Epub 2013 Sep 13.

PMID:
24026634
12.

Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia.

La Nasa G, Caocci G, Efficace F, Dessì C, Vacca A, Piras E, Sanna M, Marcias M, Littera R, Carcassi C, Lucarelli G.

Blood. 2013 Sep 26;122(13):2262-70. doi: 10.1182/blood-2013-05-502658. Epub 2013 Aug 19.

13.

Early Complete Molecular Response to First-Line Nilotinib in Two Patients with Chronic Myeloid Leukemia Carrying the p230 Transcript.

Greco M, Caocci G, La Nasa G.

Case Rep Hematol. 2013;2013:871476. doi: 10.1155/2013/871476. Epub 2013 Jul 11.

14.

Early Death in Two Patients with Acute Promyelocytic Leukemia Presenting the bcr3 Isoform, FLT3-ITD Mutation, and Elevated WT1 Level.

Greco M, Caocci G, Ledda A, Vacca A, Arras M, Celeghini I, La Nasa G.

Case Rep Hematol. 2013;2013:896394. doi: 10.1155/2013/896394. Epub 2013 Jul 7.

15.

Reactivation of hepatitis B virus infection following ruxolitinib treatment in a patient with myelofibrosis.

Caocci G, Murgia F, Podda L, Solinas A, Atzeni S, La Nasa G.

Leukemia. 2014 Jan;28(1):225-7. doi: 10.1038/leu.2013.235. Epub 2013 Aug 9. No abstract available.

PMID:
23929216
16.

Absence of activating killer immunoglobulin-like receptor genes combined with hepatitis C viral genotype is predictive of hepatocellular carcinoma.

Littera R, Zamboni F, Tondolo V, Fantola G, Chessa L, Orrù N, Sanna M, Valentini D, Cappai L, Mulargia M, Caocci G, Arras M, Floris A, Orrù S, La Nasa G, Carcassi C.

Hum Immunol. 2013 Oct;74(10):1288-94. doi: 10.1016/j.humimm.2013.05.007. Epub 2013 Jun 10.

PMID:
23756163
17.

Successful and safe stem cell mobilization using plerixafor in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia.

Caocci G, Ledda A, Floris R, Vacca A, Arras M, Greco M, Sanna M, La Nasa G.

Leuk Lymphoma. 2014 Feb;55(2):462-3. doi: 10.3109/10428194.2013.809079. Epub 2013 Jun 24. No abstract available.

PMID:
23713454
18.

Role of human leukocyte antigen-G 14-base pair polymorphism in kidney transplantation outcomes.

Littera R, Piredda G, Pani A, Frongia M, Onano B, Michittu MB, Murgia MG, Lai S, Alba F, Valentini MD, Loi V, Caocci G, Orrù S, La Nasa G, Carcassi C.

J Nephrol. 2013 Nov-Dec;26(6):1170-8. doi: 10.5301/jn.5000252. Epub 2013 Mar 6.

PMID:
23475463
19.

Homozygosity for killer immunoglobin-like receptor haplotype A predicts complete molecular response to treatment with tyrosine kinase inhibitors in chronic myeloid leukemia patients.

La Nasa G, Caocci G, Littera R, Atzeni S, Vacca A, Mulas O, Langiu M, Greco M, Orrù S, Orrù N, Floris A, Carcassi C.

Exp Hematol. 2013 May;41(5):424-31. doi: 10.1016/j.exphem.2013.01.008. Epub 2013 Feb 1.

PMID:
23380384
20.

Guillain-Barré syndrome after human herpesvirus-6 reactivation in unrelated hematopoietic stem cell transplantation.

Piras E, Caocci G, Pisano V, Orrù F, Murgia F, Sanna M, Vacca A, La Nasa G.

Leuk Lymphoma. 2013 Jun;54(6):1332-3. doi: 10.3109/10428194.2012.740560. Epub 2013 Mar 4. No abstract available.

PMID:
23088724
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk